- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
In: Trends in Microbiol. (1993) 1, 6, 209-210.
- Schlagwort
-
Immunologie
Immunsystem
Lymphozyt
Leukozyt
Immunität
Resistenz
Immunchemie
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2009
- Urheber
-
Moll, Heidrun
- URN
-
urn:nbn:de:bvb:20-opus-30975
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Moll, Heidrun
- Universität Würzburg
Entstanden
- 2009
Ähnliche Objekte (12)
Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis
Experimental cutaneous leishmaniasis: Langerhans cells internalize Leishmania major and induce an antigen-specific T-cell response.
Signaling via Interleukin-4 Receptor alpha chain during dendritic cell–mediated vaccination is required to induce protective immunity against Leishmania major in susceptible BALB/c mice
Recombinant human interleukin 2 acts as a B cell growth and differentiation promoting factor
Immunoregulation by mouse T-cell clones. II. The same H-Y-specific T helper clone can provide help for the generation of cytotoxic lymphocytes and of antibody-secreting cells.
Recombinant human interleukin 2 directly provides signals for the proliferation and functional maturation of murine B lymphocytes
Use of polyhexanide and nanomedicine approach for effective treatments of cutaneous leishmaniasis
T-cell reactivity to purified lipophosphoglycan from Leishmania major: A model for analysis of the cellular immune response to microbial carbohydrates.
L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1)
Simultaneous demonstration of two antigens with immunogold-silver staining and immunoenzymatic labeling
Mechanism of dendritic cell-based vaccination against Leishmania major
Resistance to murine cutaneous leishmaniasis is mediated by Th1 cells, but disease-promoting CD4+ cells are different from Th2 cells
Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis
Experimental cutaneous leishmaniasis: Langerhans cells internalize Leishmania major and induce an antigen-specific T-cell response.
Signaling via Interleukin-4 Receptor alpha chain during dendritic cell–mediated vaccination is required to induce protective immunity against Leishmania major in susceptible BALB/c mice
Recombinant human interleukin 2 acts as a B cell growth and differentiation promoting factor
Immunoregulation by mouse T-cell clones. II. The same H-Y-specific T helper clone can provide help for the generation of cytotoxic lymphocytes and of antibody-secreting cells.
Recombinant human interleukin 2 directly provides signals for the proliferation and functional maturation of murine B lymphocytes
Use of polyhexanide and nanomedicine approach for effective treatments of cutaneous leishmaniasis
T-cell reactivity to purified lipophosphoglycan from Leishmania major: A model for analysis of the cellular immune response to microbial carbohydrates.
L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1)
Simultaneous demonstration of two antigens with immunogold-silver staining and immunoenzymatic labeling
Mechanism of dendritic cell-based vaccination against Leishmania major
Resistance to murine cutaneous leishmaniasis is mediated by Th1 cells, but disease-promoting CD4+ cells are different from Th2 cells
Epidermal Langerhans cells are critical for immunoregulation of cutaneous leishmaniasis
Experimental cutaneous leishmaniasis: Langerhans cells internalize Leishmania major and induce an antigen-specific T-cell response.
Signaling via Interleukin-4 Receptor alpha chain during dendritic cell–mediated vaccination is required to induce protective immunity against Leishmania major in susceptible BALB/c mice
Recombinant human interleukin 2 acts as a B cell growth and differentiation promoting factor
Immunoregulation by mouse T-cell clones. II. The same H-Y-specific T helper clone can provide help for the generation of cytotoxic lymphocytes and of antibody-secreting cells.
Recombinant human interleukin 2 directly provides signals for the proliferation and functional maturation of murine B lymphocytes
Use of polyhexanide and nanomedicine approach for effective treatments of cutaneous leishmaniasis
T-cell reactivity to purified lipophosphoglycan from Leishmania major: A model for analysis of the cellular immune response to microbial carbohydrates.
L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1)
Simultaneous demonstration of two antigens with immunogold-silver staining and immunoenzymatic labeling
Mechanism of dendritic cell-based vaccination against Leishmania major